CREE » Topics » Patent and License Rights

This excerpt taken from the CREE 10-Q filed Apr 22, 2009.

Patent and License Rights

Patent rights reflect costs incurred by the Company in applying for and maintaining patents owned by the Company and in purchasing patents and related rights from third parties. License rights reflect costs incurred by the Company in acquiring licenses under patents owned by others. The Company amortizes both patent and license rights on a straight-line basis over the expected useful life of the associated rights, which is generally the lesser of 20 years from the date of the patent application or the license period. Royalties payable under licenses for patents owned by others are expensed as incurred.

 

8


Table of Contents
This excerpt taken from the CREE 10-Q filed Jan 21, 2009.

Patent and License Rights

Patent rights reflect costs incurred by the Company in applying for and maintaining patents owned by the Company and in purchasing patents and related rights from third parties. License rights reflect costs incurred by the Company in acquiring licenses under patents owned by others. The Company amortizes

 

8


Table of Contents

both on a straight-line basis over the expected useful life of the associated patent rights, which is generally the lesser of 20 years from the date of the patent application or the license period. Royalties payable under licenses for patents owned by others are expensed as incurred.

This excerpt taken from the CREE 10-K filed Aug 20, 2008.

Patent and License Rights

Patent rights reflect costs incurred by the Company in applying for and maintaining patents owned by the Company and in purchasing patents and related rights from third parties. License rights reflect costs incurred by the Company in acquiring licenses under patents owned by others. The Company amortizes both on a straight-line basis over the expected useful life of the associated patent rights, which is generally the lesser of 20 years from the date of the patent application or the license period. Royalties payable under licenses for patents owned by others are expensed as incurred.

This excerpt taken from the CREE 10-K filed Aug 22, 2007.

Patent and License Rights

Patent rights reflect costs incurred by the Company in applying for and maintaining patents owned by the Company and in purchasing patents and related rights from third parties. License rights reflect costs incurred by the Company in acquiring licenses under patents owned by others. The Company amortizes both on a straight-line basis over the expected useful life of the associated patent rights, which is generally the lesser of 20 years from the date of the patent application or the license period. Royalties payable under licenses for patents owned by others are expensed as incurred.

 

42


Table of Contents

CREE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

June 24, 2007

 

This excerpt taken from the CREE 10-K filed Aug 24, 2006.

Patent and License Rights

Patent rights reflect costs incurred by the Company in applying for and maintaining patents owned by the Company and in purchasing patents and related rights from third parties. License rights reflect costs incurred by the Company in acquiring licenses under patents owned by others. The Company amortizes both on a straight-line basis over the expected useful life of the associated patent rights, which is generally the lesser of 20 years from the date of the patent application or the license period. Royalties payable under licenses for patents owned by others are expensed as incurred.

This excerpt taken from the CREE 10-K filed Aug 18, 2005.

Patent and License Rights

 

Patent rights reflect costs incurred to enhance and maintain the Company’s intellectual property position. License rights reflect costs incurred to use the intellectual property of others. The Company amortizes both on a straight-line basis over the lesser of 20 years from the date of patent application or over the license period. The Company invested $10.8 million, $13.8 million and $3.3 million for the years ended June 26, 2005, June 27, 2004 and June 29, 2003, respectively for patent and license rights. The estimated aggregate amortization estimated for patent and license rights for fiscal 2006, fiscal 2007, fiscal 2008, fiscal 2009 and fiscal 2010 is $2.3 million, $2.2 million, $2.2 million, $2.2 million and $2.2 million, respectively.

 

The following is a summary of patent and license rights:

 

     As of and for Year Ended

 
     June 26,
2005


    June 27,
2004


    June 29,
2003


 

Patent and license rights, gross

   $ 33,377     $ 22,493     $ 8,815  

Accumulated amortization

     (4,486 )     (2,662 )     (1,669 )
    


 


 


Patent and license rights, net

   $ 28,891     $ 19,831     $ 7,146  
    


 


 


Amortization expense for patent and license rights

   $ 1,843     $ 994     $ 394  
    


 


 


 

58


Table of Contents

CREE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

June 26, 2005

 

This excerpt taken from the CREE 10-Q filed Feb 2, 2005.

Patent and License Rights

 

Patent rights reflect costs incurred to enhance and maintain the Company’s intellectual property position. License rights reflect costs incurred to use the intellectual property of others. Both are

 

15


Table of Contents

amortized on a straight-line basis over the lesser of 20 years from the date of patent application or over the license period. The related amortization expense was $397,000 and $803,000 for the three and six months ended December 26, 2004, respectively. The related amortization expense was $204,000 and $387,000 for the three and six months ended December 28, 2003, respectively.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki